Description
Medical Implant Market Analysis
Market Overview
The medical implant market is projected to enlist a CAGR of 8.20% toward the finish of 2027 to reach 89.25 billion by 2027. A few key reasons impelling the medical implants industry are the maturing populace and the ascent in persistent sicknesses. Matured people are the fundamental customers of medical implants since they are more inclined to constant diseases, for example, cardiovascular, orthopedic, endovascular, and dental sicknesses.
For example, it is guessed that the interest in tooth misfortune will increment as the populace ages. Medical implant innovation advancements are another variable energizing the development of the overall market for medical implants. Expanded dispensable cash, working in medical offices, and expanded events of harmed organs or appendages welcomed on by mishaps are a few reasons helping the extension of the medical implants industry.
The medical implant industry is developing as medical care experts become more learned about the numerous sorts of medical implants.
The quick ascent in geriatrics, who are more defenseless to orthopedic issues, and the rising frequency of orthopedic problems, for example, osteoarthritis and joint pain are driving the market’s development.
The market’s development is additionally upheld by specialized headways like robot-helped careful instruments, the reception of implanted medical gadgets, and the inescapable utilization of orthopedic implants to treat outer muscle and orthopedic ailments, and wounds.
In any case, costly medicines, including orthopedic implants for treatment, and severe unofficial laws, control market extension. Moreover, developing economies furnish the market with beneficial possibilities.
Market Segmentation
Orthopedic implants, cardiac implants, spinal implants, dental implants, ophthalmic implants, and cosmetic implants are the different types of medical implants.
Metal, ceramic, and polymer materials make up the three segments of the medical implant industry according to the type of material. A 50% market share is held by the category of metallic materials, which includes items like titanium alloys, cobalt-chromium steels, and stainless steel.
Hospitals & clinics and research labs are the two market segments that are broken down based on the end user.
Regional Analysis
North America represented the broadest market share. Because of the great pervasiveness of persistent sicknesses, state-of-the-art innovation, and item deliveries around here, America controls an extensive offer. The expanded interest in medical implants and the availability of qualified experts drive market extension around here. As per a distributed by the US government, the US has the biggest medical gadget market on the planet.
The market with the quickest projected development will probably be Asia-Pacific. The development of the business is being energized by the expanded government spending nearby on making state of an art medical care foundations. Moreover, an expansion in car crashes might build interest in medical implants.
Around 93% of streetcar crash episodes, as per the WHO, are accounted for in low-and center pay countries. Also, the Region’s maturing populace is one more significant component expected to right away fuel market extension.
Major Players
Prominent players in the medical implants market research include Boston Scientific Corporation (US), Johnson & Johnson (US), Stryker Corporation (US), 3M (US), Zimmer Biomet (US), and others.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 16
2.2 RESEARCH OBJECTIVE 16
2.3 LIST OF ASSUMPTIONS & LIMITATIONS 17
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 19
3.2 DATA MINING 19
3.3 SECONDARY RESEARCH 20
3.4 PRIMARY RESEARCH 21
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 22
3.5 FORECASTING TECHNIQUES 23
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24
3.6.1 BOTTOM-UP APPROACH 24
3.6.2 TOP-DOWN APPROACH 25
3.7 DATA TRIANGULATION 26
3.8 VALIDATION 26
4 MARKET DYNAMICS
4.1 OVERVIEW 27
4.2 DRIVERS 28
4.2.1 IMPROVEMENT IN SURGICAL OUTCOMES 28
4.2.2 INCREASING PREVALENCE OF CHRONIC DISEASES 28
4.2.3 GROWING GERIATRIC POPULATION 29
4.3 RESTRAINTS 30
4.3.1 AMBIGUOUS REGULATORY FRAMEWORK 30
4.3.2 RISK OF INFECTIONS DUE TO MEDICAL IMPLANTS 30
4.4 OPPORTUNITY 31
4.4.1 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL IMPLANTS 31
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 33
5.1.1 R&D AND DESIGNING 34
5.1.2 MANUFACTURING 34
5.1.3 DISTRIBUTION 34
5.1.4 MARKETING & SALES 34
5.2 PORTER’S FIVE FORCES MODEL 35
5.2.1 THREAT OF NEW ENTRANTS 36
5.2.2 BARGAINING POWER OF SUPPLIERS 36
5.2.3 THREAT OF SUBSTITUTES 36
5.2.4 BARGAINING POWER OF BUYERS 36
5.2.5 INTENSITY OF RIVALRY 36
5.3 IMPACT OF COVID-19 37
5.3.1 IMPACT ON DEMAND 37
5.3.2 IMPACT ON SUPPLY 37
5.3.3 IMPACT ON MARKET PLAYER 37
6 GLOBAL MEDICAL IMPLANT MARKET, BY TYPE
6.1 OVERVIEW 38
6.2 ORTHOPEDIC IMPLANTS 39
6.3 CARDIAC IMPLANTS 40
6.4 SPINAL IMPLANTS 41
6.5 DENTAL IMPLANTS 42
6.6 OPHTHALMIC IMPLANTS 43
6.7 COSMETIC IMPLANTS 44
6.8 OTHERS 45
7 GLOBAL MEDICAL IMPLANT MARKET, BY TYPE OF MATERIAL
7.1 OVERVIEW 46
7.2 METALLIC MATERIAL 47
7.3 CERAMIC MATERIAL 47
7.4 POLYMERS MATERIAL 48
7.5 OTHERS 49
8 GLOBAL MEDICAL IMPLANTSMARKET, BY END USER
8.1 OVERVIEW 50
8.2 HOSPITALS & CLINICS 51
8.3 SPECIALTY CENTRES 51
8.4 OTHERS 52
9 GLOBAL MEDICAL IMPLANT MARKET, BY REGION
9.1 OVERVIEW 53
9.2 AMERICAS 54
9.2.1 NORTH AMERICA 57
9.2.1.1 US 60
9.2.1.2 CANADA 62
9.2.2 LATIN AMERICA 64
9.3 EUROPE 67
9.3.1 WESTERN EUROPE 70
9.3.1.1 GERMANY 73
9.3.1.2 FRANCE 75
9.3.1.3 UK 77
9.3.1.4 ITALY 79
9.3.1.5 SPAIN 81
9.3.1.6 REST OF WESTERN OF EUROPE 83
9.3.2 EASTERN EUROPE 85
9.4 ASIA-PACIFIC 88
9.4.1 JAPAN 91
9.4.2 CHINA 93
9.4.3 INDIA 95
9.4.4 AUSTRALIA 97
9.4.5 SOUTH KOREA 99
9.4.6 REST OF ASIA-PACIFIC 101
9.5 MIDDLE EAST & AFRICA 104
9.5.1 MIDDLE EAST 107
9.5.2 AFRICA 109
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 112
10.2 GLOBAL MEDICAL IMPLANT MARKET SHARE ANALYSIS (2019) 112
10.3 COMPETITIVE BENCHMARKING 113
10.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL MEDICAL IMPLANTS MARKET 114
10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL IMPLANTS MARKET 114
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 115
10.6.1 EXPANSION 115
10.6.2 PRODUCT APPROVAL/FDA APPROVAL 116
11 COMPANY PROFILES
11.1 BOSTON SCIENTIFIC CORPORATION 117
11.1.1 COMPANY OVERVIEW 117
11.1.2 FINANCIAL OVERVIEW 117
11.1.3 PRODUCTS/SERVICES OFFERED 118
11.1.4 KEY DEVELOPMENTS 119
11.1.5 SWOT ANALYSIS 120
11.1.6 KEY STRATEGIES 120
11.2 MEDTRONIC PLC 121
11.2.1 COMPANY OVERVIEW 121
11.2.2 FINANCIAL OVERVIEW 121
11.2.3 PRODUCTS/SERVICES OFFERED 122
11.2.4 KEY DEVELOPMENTS 124
11.2.5 SWOT ANALYSIS 125
11.2.6 KEY STRATEGIES 125
11.3 JOHNSON & JOHNSON SERVICES, INC. 126
11.3.1 COMPANY OVERVIEW 126
11.3.2 FINANCIAL OVERVIEW 126
11.3.3 PRODUCTS/SERVICES OFFERED 127
11.3.4 KEY DEVELOPMENTS 127
11.3.5 SWOT ANALYSIS 128
11.3.6 KEY STRATEGIES 128
11.4 3M 129
11.4.1 COMPANY OVERVIEW 129
11.4.2 FINANCIAL OVERVIEW 129
11.4.3 PRODUCTS/SERVICES OFFERED 130
11.4.4 KEY DEVELOPMENTS 130
11.4.5 SWOT ANALYSIS 131
11.4.6 KEY STRATEGIES 131
11.5 INSTITUT STRAUMANN AG 132
11.5.1 COMPANY OVERVIEW 132
11.5.2 FINANCIAL OVERVIEW 132
11.5.3 PRODUCTS/SERVICES OFFERED 133
11.5.4 KEY DEVELOPMENTS 134
11.5.5 SWOT ANALYSIS 135
11.5.6 KEY STRATEGIES 135
11.6 STRYKER 136
11.6.1 COMPANY OVERVIEW 136
11.6.2 FINANCIAL OVERVIEW 136
11.6.3 PRODUCTS/SERVICES OFFERED 137
11.6.4 KEY DEVELOPMENTS 137
11.6.5 SWOT ANALYSIS 138
11.6.6 KEY STRATEGIES 138
11.7 ZIMMER BIOMET HOLDINGS INC. 139
11.7.1 COMPANY OVERVIEWS 139
11.7.2 FINANCIAL OVERVIEW 139
11.7.3 PRODUCTS/SERVICES OFFERED 140
11.7.4 KEY DEVELOPMENTS 140
11.7.5 SWOT ANALYSIS 141
11.7.6 KEY STRATEGIES 141
11.8 SMITH & NEPHEW 142
11.8.1 COMPANY OVERVIEW 142
11.8.2 FINANCIAL OVERVIEW 142
11.8.3 PRODUCTS/SERVICES OFFERED 143
11.8.4 KEY DEVELOPMENTS 143
11.8.5 SWOT ANALYSIS 144
11.8.6 KEY STRATEGIES 144
11.9 DENTSPLY SIRONA 145
11.9.1 COMPANY OVERVIEW 145
11.9.2 FINANCIAL OVERVIEW 145
11.9.3 PRODUCTS/SERVICES OFFERED 146
11.9.4 KEY DEVELOPMENTS 146
11.9.5 SWOT ANALYSIS 147
11.9.6 KEY STRATEGIES 147
11.10 B. BRAUN MELSUNGEN AG 148
11.10.1 COMPANY OVERVIEW 148
11.10.2 FINANCIAL OVERVIEW 148
11.10.3 PRODUCTS/SERVICES OFFERED 149
11.10.4 KEY DEVELOPMENTS 149
11.10.5 SWOT ANALYSIS 150
11.10.6 KEY STRATEGIES 150
12 APPENDIX
12.1 REFERENCES 151
12.2 RELATED REPORTS 151
